Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
188.83
-3.40 (-1.77%)
At close: Jun 2, 2026, 4:00 PM EDT
189.00
+0.17 (0.09%)
After-hours: Jun 2, 2026, 7:34 PM EDT
Biogen Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9,937 | 9,891 | 9,676 | 9,836 | 10,173 | 10,982 | |
Revenue Growth (YoY) | 1.23% | 2.22% | -1.62% | -3.32% | -7.36% | -18.32% |
Cost of Revenue | 2,436 | 2,404 | 2,310 | 2,533 | 2,278 | 2,110 |
Gross Profit | 7,502 | 7,486 | 7,366 | 7,302 | 7,895 | 8,872 |
Selling, General & Admin | 2,468 | 2,434 | 2,404 | 2,550 | 2,404 | 2,674 |
Depreciation & Amortization Expenses | 539.7 | 515 | 446.7 | 240.6 | 365.9 | 881.3 |
Research & Development | 2,189 | 2,250 | 2,042 | 2,462 | 2,231 | 2,519 |
Other Operating Expenses | 424.9 | 425.3 | 223.7 | 437.6 | -589.1 | -43.5 |
Total Operating Expenses | 5,622 | 5,624 | 5,116 | 5,690 | 4,412 | 6,031 |
Operating Income | 1,880 | 1,862 | 2,250 | 1,612 | 3,484 | 2,841 |
Total Non-Operating Income (Expense) | 212.4 | 272 | 227.3 | 315.5 | -402.8 | 50.7 |
Pretax Income | 1,623 | 1,557 | 1,906 | 1,297 | 3,592 | 1,745 |
Provision for Income Taxes | 251.1 | 263.6 | 273.8 | 135.3 | 632.8 | 52.5 |
Net Income | 737.1 | 1,293 | 1,632 | 1,161 | 2,962 | 1,728 |
Minority Interest in Earnings | - | - | - | 0.4 | -87.9 | 136.6 |
Net Income to Common | 737.1 | 1,293 | 1,632 | 1,161 | 2,962 | 1,728 |
Net Income Growth | -17.71% | -20.79% | 40.57% | -60.80% | 71.43% | -57.45% |
Shares Outstanding (Basic) | 147 | 147 | 146 | 145 | 145 | 149 |
Shares Outstanding (Diluted) | 147 | 147 | 146 | 146 | 146 | 150 |
Shares Change (YoY) | 0.72% | 0.82% | 0.21% | -0.27% | -2.41% | -7.25% |
EPS (Basic) | 9.35 | 8.83 | 11.21 | 8.02 | 20.96 | 10.44 |
EPS (Diluted) | 9.32 | 8.79 | 11.18 | 7.97 | 20.87 | 10.40 |
EPS Growth | -8.00% | -21.38% | 40.28% | -61.81% | 100.67% | -58.06% |
Shares Outstanding | 147.6 | 146.7 | 145.8 | 144.9 | 144.1 | 147 |
Free Cash Flow | 2,423 | 2,051 | 2,722 | 1,270 | 1,144 | 3,382 |
Free Cash Flow Growth | 18.14% | -24.65% | 114.28% | 11.03% | -66.17% | -11.12% |
Free Cash Flow Per Share | 16.46 | 13.94 | 18.66 | 8.72 | 7.84 | 22.61 |
Gross Margin | 75.49% | 75.69% | 76.12% | 74.24% | 77.61% | 80.79% |
Operating Margin | 18.92% | 18.83% | 23.25% | 16.39% | 34.24% | 25.87% |
Profit Margin | 7.42% | 13.07% | 16.87% | 11.81% | 29.11% | 15.73% |
FCF Margin | 24.38% | 20.73% | 28.13% | 12.91% | 11.24% | 30.79% |
EBITDA | 2,681 | 2,642 | 2,923 | 2,107 | 4,002 | 3,328 |
EBITDA Margin | 26.98% | 26.71% | 30.21% | 21.42% | 39.34% | 30.31% |
EBIT | 1,880 | 1,862 | 2,250 | 1,612 | 3,484 | 2,841 |
EBIT Margin | 18.92% | 18.83% | 23.25% | 16.39% | 34.24% | 25.87% |
Effective Tax Rate | 15.47% | 16.94% | 14.37% | 10.43% | 17.62% | 3.01% |